Prevention of the degeneration of human dopaminergic neurons in an astrocyte co-culture system allowing endogenous drug metabolism
about
Functional metabolic interactions of human neuron-astrocyte 3D in vitro networksReference compounds for alternative test methods to indicate developmental neurotoxicity (DNT) potential of chemicals: example lists and criteria for their selection and use.Identification of transcriptome signatures and biomarkers specific for potential developmental toxicants inhibiting human neural crest cell migration.A LUHMES 3D dopaminergic neuronal model for neurotoxicity testing allowing long-term exposure and cellular resilience analysis.3D Differentiation of LUHMES Cell Line to Study Recovery and Delayed Neurotoxic Effects.In vitro acute and developmental neurotoxicity screening: an overview of cellular platforms and high-throughput technical possibilities.Switching from astrocytic neuroprotection to neurodegeneration by cytokine stimulation.Arsenolipids exert less toxicity in a human neuron astrocyte co-culture as compared to the respective monocultures.Functional and phenotypic differences of pure populations of stem cell-derived astrocytes and neuronal precursor cells.Investigation into experimental toxicological properties of plant protection products having a potential link to Parkinson's disease and childhood leukaemia†Neuroprotective effects of the gliopeptide ODN in an in vivo model of Parkinson's disease.Human Co-culture Model of Neurons and Astrocytes to Test Acute Cytotoxicity of Neurotoxic Compounds.Can Astrocytes Be a Target for Precision Medicine?An adverse outcome pathway for parkinsonian motor deficits associated with mitochondrial complex I inhibition.Atp13a2 Deficiency Aggravates Astrocyte-Mediated Neuroinflammation via NLRP3 Inflammasome Activation.Bioorthogonally Functionalized NAD(+) Analogues for In-Cell Visualization of Poly(ADP-Ribose) Formation.
P2860
Q26970775-C8500C97-FF58-487E-9BAE-CC370010E75DQ30835700-5268A2EE-437B-415A-BB9B-411404893F41Q36456362-E3ED0D25-8D44-4672-968A-61CEFCB8B347Q37341837-A38A1D3F-3569-440F-899E-F71C5D980CFBQ38695716-F306A6FE-1F03-47C0-8FE6-3A557AB733B4Q38753758-B948C4AF-5992-478C-ACA4-96DBE63B8859Q38780192-ED779DAE-E5C8-4CF2-806C-1A7738AFFF30Q38823521-61AB076C-3950-497C-A165-86AB31895647Q40187211-43E91A72-6418-4662-BCFD-515392FB602CQ47159009-A1208C7C-78EC-4B4F-B43C-72B9C8EED980Q47267653-12B3CCA9-78BE-49E5-B61F-F2D862239B31Q47447918-5BD390F4-24E2-4E8A-9BB3-A7EF756CF78DQ48140499-FE3F4460-0402-4030-BD47-E2B053AFFCF9Q48171351-B8DA4354-C476-492B-968F-80B6293E44E2Q48925750-D4D3A16F-B9D5-45DE-BC83-E3A578802833Q53140423-51E2F3F4-9EAE-4730-AAD2-3A5EFFC0F43B
P2860
Prevention of the degeneration of human dopaminergic neurons in an astrocyte co-culture system allowing endogenous drug metabolism
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Prevention of the degeneration ...... ing endogenous drug metabolism
@ast
Prevention of the degeneration ...... ing endogenous drug metabolism
@en
type
label
Prevention of the degeneration ...... ing endogenous drug metabolism
@ast
Prevention of the degeneration ...... ing endogenous drug metabolism
@en
prefLabel
Prevention of the degeneration ...... ing endogenous drug metabolism
@ast
Prevention of the degeneration ...... ing endogenous drug metabolism
@en
P2093
P2860
P356
P1476
Prevention of the degeneration ...... ing endogenous drug metabolism
@en
P2093
Alexander Bürkle
Benjamin Hanf
Liudmila Efremova
Martina Adam
Regina Pape
Simon Gutbier
Stefan Schildknecht
P2860
P304
P356
10.1111/BPH.13193
P407
P50
P577
2015-06-26T00:00:00Z